These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23405123)

  • 1. Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer.
    Jeon JY; Jeong DH; Park MG; Lee JW; Chu SH; Park JH; Lee MK; Sato K; Ligibel JA; Meyerhardt JA; Kim NK
    PLoS One; 2013; 8(2):e55196. PubMed ID: 23405123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.
    Yeh CC; Lai CY; Chang SN; Hsieh LL; Tang R; Sung FC; Lin YK
    Int J Clin Oncol; 2017 Jun; 22(3):484-493. PubMed ID: 28044213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients.
    Trepanier M; Paradis T; Kouyoumdjian A; Dumitra T; Charlebois P; Stein BS; Liberman AS; Schwartzman K; Carli F; Fried GM; Feldman LS; Lee L
    J Gastrointest Surg; 2020 Jan; 24(1):115-122. PubMed ID: 31367895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
    Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
    Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.
    Renouf DJ; Woods R; Speers C; Hay J; Phang PT; Fitzgerald C; Kennecke H
    Am J Clin Oncol; 2013 Dec; 36(6):558-64. PubMed ID: 22868238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
    Ng K; Ogino S; Meyerhardt JA; Chan JA; Chan AT; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Bertagnolli MM; Venook AP; Fuchs CS
    J Natl Cancer Inst; 2011 Oct; 103(20):1540-51. PubMed ID: 21849660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
    Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
    Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.
    Lee SHF; Abdul Rahman H; Abidin N; Ong SK; Leong E; Naing L
    BMC Cancer; 2021 Apr; 21(1):477. PubMed ID: 33926405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SURVIVAL OF PATIENTS WITH COLORECTAL CANCER IN A CANCER CENTER.
    Aguiar Junior S; Oliveira MM; Silva DRME; Mello CAL; Calsavara VF; Curado MP
    Arq Gastroenterol; 2020; 57(2):172-177. PubMed ID: 33206858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer.
    Rashtak S; Ruan X; Druliner BR; Liu H; Therneau T; Mouchli M; Boardman LA
    Clin Colorectal Cancer; 2017 Jun; 16(2):115-123.e3. PubMed ID: 28365393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal specialization and survival in colorectal cancer.
    Hall GM; Shanmugan S; Bleier JI; Jeganathan AN; Epstein AJ; Paulson EC
    Colorectal Dis; 2016 Feb; 18(2):O51-60. PubMed ID: 26708838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Radial Margin in Patients Undergoing Complete Mesocolic Excision for Colon Cancer.
    Lee JM; Chung T; Kim KM; Simon NSM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Lee SB; Kim GR; Min BS
    Dis Colon Rectum; 2020 Apr; 63(4):488-496. PubMed ID: 31977585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
    Suthananthan AE; Bhandari M; Platell C
    ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer.
    Nedrebø BS; Søreide K; Eriksen MT; Kvaløy JT; Søreide JA; Kørner H
    Acta Oncol; 2013 Jun; 52(5):933-40. PubMed ID: 23101468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
    Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.